UBS ASSET MANAGEMENT AMERICAS LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 260 filers reported holding MYRIAD GENETICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,497,671
-25.4%
93,371
+8.1%
0.00%0.0%
Q2 2023$2,007,2350.0%86,4070.0%0.00%0.0%
Q1 2023$2,007,235
+91.6%
86,407
+19.7%
0.00%0.0%
Q4 2022$1,047,795
-99.9%
72,212
-3.4%
0.00%0.0%
Q3 2022$1,426,383,000
+2.1%
74,758
-2.8%
0.00%0.0%
Q2 2022$1,396,908,000
-48.4%
76,880
-28.4%
0.00%0.0%
Q1 2022$2,707,160,000
-8.9%
107,427
-0.2%
0.00%0.0%
Q4 2021$2,971,305,000
-17.6%
107,656
-3.6%
0.00%0.0%
Q3 2021$3,606,051,000
+18.1%
111,677
+11.8%
0.00%0.0%
Q2 2021$3,054,636,000
+24.1%
99,890
+23.6%
0.00%0.0%
Q1 2021$2,460,604,000
+61.7%
80,808
+5.0%
0.00%0.0%
Q4 2020$1,521,687,000
+46.2%
76,950
-3.6%
0.00%0.0%
Q3 2020$1,041,035,000
+15.0%
79,8340.0%0.00%0.0%
Q2 2020$905,317,000
-32.5%
79,834
-14.9%
0.00%0.0%
Q1 2020$1,341,949,000
-49.3%
93,777
-3.5%
0.00%
-50.0%
Q4 2019$2,645,096,000
-3.3%
97,139
+1.7%
0.00%0.0%
Q3 2019$2,734,623,000
+16.5%
95,516
+13.0%
0.00%0.0%
Q2 2019$2,347,187,000
-3.0%
84,492
+15.9%
0.00%0.0%
Q1 2019$2,420,811,000
+45.8%
72,916
+27.7%
0.00%
+100.0%
Q4 2018$1,659,984,000
-25.6%
57,103
+17.8%
0.00%
-50.0%
Q3 2018$2,230,402,000
+36.6%
48,487
+11.0%
0.00%
+100.0%
Q2 2018$1,632,211,000
+6.4%
43,677
-15.9%
0.00%0.0%
Q1 2018$1,534,472,000
-12.3%
51,928
+1.9%
0.00%0.0%
Q4 2017$1,750,016,000
+0.1%
50,954
+5.4%
0.00%
-50.0%
Q3 2017$1,748,905,000
+50.7%
48,339
+7.6%
0.00%
+100.0%
Q2 2017$1,160,448,000
+75.9%
44,909
+30.7%
0.00%0.0%
Q1 2017$659,788,000
+166934.9%
34,364
+45.0%
0.00%
Q4 2016$395,000
-56.7%
23,697
-46.5%
0.00%
-100.0%
Q3 2016$912,000
-35.4%
44,297
-4.0%
0.00%
-50.0%
Q2 2016$1,411,000
-62.0%
46,123
-53.6%
0.00%
-50.0%
Q1 2016$3,718,000
-16.8%
99,320
-4.1%
0.00%
-20.0%
Q4 2015$4,469,000
+5.9%
103,535
-8.1%
0.01%0.0%
Q3 2015$4,222,000
+19.9%
112,630
+8.8%
0.01%
+66.7%
Q2 2015$3,520,000
-22.6%
103,551
-19.4%
0.00%
-25.0%
Q1 2015$4,549,000
+29.2%
128,500
+24.3%
0.00%
+33.3%
Q4 2014$3,522,000
-14.9%
103,400
-3.7%
0.00%
-25.0%
Q3 2014$4,140,000
-3.2%
107,342
-2.4%
0.00%0.0%
Q2 2014$4,278,000
-82.1%
109,942
-84.3%
0.00%
-84.6%
Q1 2014$23,925,000
+59.9%
699,763
-1.9%
0.03%
+52.9%
Q4 2013$14,967,000
-1.9%
713,404
+9.9%
0.02%
-10.5%
Q3 2013$15,257,000
+45.6%
649,238
+66.5%
0.02%
+35.7%
Q2 2013$10,480,000390,0380.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 160,434$4,457,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 231,875$6,441,0003.04%
SG Capital Management LLC 501,818$13,941,0002.21%
DISCIPLINED GROWTH INVESTORS INC /MN 2,707,364$75,211,0001.40%
Global Alpha Capital Management Ltd. 269,000$7,473,0001.30%
S&T BANK/PA 166,772$4,633,0001.02%
MARATHON CAPITAL MANAGEMENT 79,460$2,207,0000.90%
Taylor Frigon Capital Management LLC 45,903$1,275,0000.88%
PURA VIDA INVESTMENTS, LLC 200,000$5,556,0000.84%
Millrace Asset Group, Inc. 29,222$812,0000.84%
View complete list of MYRIAD GENETICS INC shareholders